With a conventional laboratory test, determining a patient’s ASO (Anti-Streptolysin-O) level may take up to two days. Through faster point-of-care diagnostics with a whole blood ASO test a protracted course of disease and major complications can … Continue reading
Tuesday, 19. January 2016
Cancer screening parameter FOB now on Eurolyser point-of-care instruments The presence of hemoglobin (the major protein in red blood cells) in feces is indicative for the presence of blood (faecal occult blood, FOB) as a result … Continue reading
Wednesday, 1. July 2015
Eurolyser introduces a new whole blood test parameter for CUBE and smart point-of-care instruments: ASO The parameter Antistreptolysin O (ASO) is an antibody targeted against streptolysin O, a toxic enzyme produced by group A Streptococcus … Continue reading
Tuesday, 23. June 2015
After months of developing and testing the day has come: we proudly announce the release of the latest software version (3.0) for the Eurolyser CUBE Tablet PC! With this update users will enjoy a significant and … Continue reading
Tuesday, 2. December 2014
The beginning 2015 brings an international medicine fair: Eurolyser will be exhibiting at the Arab Health 2015 in Dubai. Find us in Rashid Hall at Stand RK 18. Our team is looking forward to having you! … Continue reading
Wednesday, 12. November 2014
The pocket format laboratory becomes more versatile than ever! Eurolyser is proud to announce another milestone for the CUBE: substantial improvements in the test-kit design which allows a significant extension regarding the range of assays … Continue reading